New Enterprise Associates 14, L.P. (CIK 0001544328)

Latest company ownership

Shares held
82,978,668
Last filed at
Sep 10, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
5,959,520
Last filed at
Sep 16, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
SYBX - SYNLOGIC, INC.
Role: 10% Owner
Shares held
2,922,773
Last filed at
Oct 6, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
APPN - APPIAN CORP
Role: 10% Owner
Shares held
2,724,202
Last filed at
Feb 15, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
2,611,050
Last filed at
Apr 7, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
859,375
Last filed at
Mar 10, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
267,935
Last filed at
Nov 12, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 5, 2022 Apr 7, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 20.0 -694,551 -21.01% ✗ $751.3K
Jan 21, 2022 Jan 25, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 22.5 -134,558 -3.91% ✗ $202.2K
Jan 18, 2022 Jan 20, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 36.3 -26,555 -0.77% ✗ $48.7K
Jan 12, 2022 Jan 14, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 36.3 -21,550 -0.62% ✗ $41.8K
Jan 7, 2022 Jan 11, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 36.3 -18,760 -0.53% ✗ $38.7K
Jan 4, 2022 Jan 6, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 32.5 -31,916 -0.90% ✗ $72.2K
Dec 30, 2021 Jan 3, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 20.0 -116,476 -3.19% ✗ $266.9K
Dec 27, 2021 Dec 29, 2021 Enliven Therapeutics, Inc. 10% Owner Sell 22.5 -67,427 -1.81% ✗ $159.5K
Dec 9, 2021 Dec 27, 2021 Enliven Therapeutics, Inc. 10% Owner Sell 20.0 -291,152 -7.25% ✗ $688.5K
Aug 28, 2019 Apr 13, 2020 Mersana Therapeutics, Inc. 10% Owner Sell 52.5 -1,211 -0.01% ✗ $3.5K
Mar 16, 2020 Mar 16, 2020 Enliven Therapeutics, Inc. 10% Owner Buy 100.0 +475,000 13.42% ✗ $7.6M
Mar 6, 2020 Mar 10, 2020 CHAMPIONS ONCOLOGY, INC. 10% Owner Sell 17.5 -708,155 -29.24% ✗ $5M
Nov 12, 2019 Nov 12, 2019 Galera Therapeutics, Inc. 10% Owner Buy 100.0 +416,666 10.57% ✗ $5M
Mar 5, 2019 Mar 6, 2019 Mersana Therapeutics, Inc. 10% Owner Buy 100.0 +3,750,000 46.07% ✗ $15M
Sep 7, 2018 Sep 10, 2018 Adaptimmune Therapeutics PLC 10% Owner Buy 93.8 +3,000,000 3.75% ✗ $5M
Mar 26, 2018 Mar 28, 2018 Adaptimmune Therapeutics PLC 10% Owner Buy 97.5 +6,571,164 8.95% ✗ $12.6M
Mar 21, 2018 Mar 23, 2018 Adaptimmune Therapeutics PLC 10% Owner Buy 87.5 +1,268,508 1.76% ✗ $2.4M
Nov 27, 2017 Nov 27, 2017 APPIAN CORP 10% Owner Sell 15.0 -569,620 -100.00% ✗ $11.1M
Nov 20, 2017 Nov 21, 2017 APPIAN CORP 10% Owner Sell 15.0 -2,820,516 -100.00% ✗ $55M
Jul 3, 2017 Jul 6, 2017 Mersana Therapeutics, Inc. 10% Owner Buy 100.0 +1,000,000 14.01% ✗ $15M
Mar 27, 2017 Mar 28, 2017 Adaptimmune Therapeutics PLC 10% Owner Buy 100.0 +12,870,000 21.71% ✗ $9M
Oct 5, 2015 Oct 6, 2015 SYNLOGIC, INC. 10% Owner Buy 100.0 +1,146,308 21.08% ✗ $6M